- call +1-201-465-4211
- email sales@mrinsights.biz
Diabetes is a metabolic disorder in which the body glucose level is elevated. There are two type of diabetes namely type-1 diabetes and type-2 diabetes. During last decade there is a tremendous increase in the number of diabetic population.
Scope of the Report:
This report focuses on the Diabetes Drug in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
The analysis shows human insulins and analogues dominated the antidiabetics market in 2017.
The worldwide market for Diabetes Drug is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new study.
Market Segment by Manufacturers, this report covers
Eli Lilly
Novo Nordisk
Abbott
AstraZeneca
Biocon
Sunpharma
Sanofi
Novartis
Merck
Pfizer
Daiichi Sankyo
Boehringer Ingelheim
Akros Pharma
Amgen
Adocia
Peptron
Takeda
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Insulin
Sensitizers
SGLT-2 Inhibitors
Alpha-glucosidase Inhibitors
Secretagogues
Peptide Analogs
Others
Market Segment by Applications, can be divided into
Hospital
Clinic
Others
There are 15 Chapters to deeply display the global Diabetes Drug market.
Chapter 1, to describe Diabetes Drug Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Diabetes Drug, with sales, revenue, and price of Diabetes Drug, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Diabetes Drug, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Diabetes Drug market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Diabetes Drug sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Diabetes Drug Introduction
1.2 Market Analysis by Type
1.2.1 Insulin
1.2.2 Sensitizers
1.2.3 SGLT-2 Inhibitors
1.2.4 Alpha-glucosidase Inhibitors
1.2.5 Secretagogues
1.2.6 Peptide Analogs
1.2.7 Others
1.3 Market Analysis by Applications
1.3.1 Hospital
1.3.2 Clinic
1.3.3 Others
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Eli Lilly
2.1.1 Business Overview
2.1.2 Diabetes Drug Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Eli Lilly Diabetes Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Novo Nordisk
2.2.1 Business Overview
2.2.2 Diabetes Drug Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Novo Nordisk Diabetes Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Abbott
2.3.1 Business Overview
2.3.2 Diabetes Drug Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Abbott Diabetes Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 AstraZeneca
2.4.1 Business Overview
2.4.2 Diabetes Drug Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 AstraZeneca Diabetes Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Biocon
2.5.1 Business Overview
2.5.2 Diabetes Drug Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Biocon Diabetes Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Sunpharma
2.6.1 Business Overview
2.6.2 Diabetes Drug Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Sunpharma Diabetes Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Sanofi
2.7.1 Business Overview
2.7.2 Diabetes Drug Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Sanofi Diabetes Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Novartis
2.8.1 Business Overview
2.8.2 Diabetes Drug Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Novartis Diabetes Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Merck
2.9.1 Business Overview
2.9.2 Diabetes Drug Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Merck Diabetes Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 Pfizer
2.10.1 Business Overview
2.10.2 Diabetes Drug Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Pfizer Diabetes Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.11 Daiichi Sankyo
2.11.1 Business Overview
2.11.2 Diabetes Drug Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Daiichi Sankyo Diabetes Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.12 Boehringer Ingelheim
2.12.1 Business Overview
2.12.2 Diabetes Drug Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Boehringer Ingelheim Diabetes Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.13 Akros Pharma
2.13.1 Business Overview
2.13.2 Diabetes Drug Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 Akros Pharma Diabetes Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.14 Amgen
2.14.1 Business Overview
2.14.2 Diabetes Drug Type and Applications
2.14.2.1 Product A
2.14.2.2 Product B
2.14.3 Amgen Diabetes Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.15 Adocia
2.15.1 Business Overview
2.15.2 Diabetes Drug Type and Applications
2.15.2.1 Product A
2.15.2.2 Product B
2.15.3 Adocia Diabetes Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.16 Peptron
2.16.1 Business Overview
2.16.2 Diabetes Drug Type and Applications
2.16.2.1 Product A
2.16.2.2 Product B
2.16.3 Peptron Diabetes Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.17 Takeda
2.17.1 Business Overview
2.17.2 Diabetes Drug Type and Applications
2.17.2.1 Product A
2.17.2.2 Product B
2.17.3 Takeda Diabetes Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Diabetes Drug Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Diabetes Drug Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Diabetes Drug Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Diabetes Drug Manufacturer Market Share in 2017
3.3.2 Top 6 Diabetes Drug Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Diabetes Drug Market Analysis by Regions
4.1 Global Diabetes Drug Sales, Revenue and Market Share by Regions
4.1.1 Global Diabetes Drug Sales and Market Share by Regions (2013-2018)
4.1.2 Global Diabetes Drug Revenue and Market Share by Regions (2013-2018)
4.2 North America Diabetes Drug Sales and Growth Rate (2013-2018)
4.3 Europe Diabetes Drug Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Diabetes Drug Sales and Growth Rate (2013-2018)
4.5 South America Diabetes Drug Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Diabetes Drug Sales and Growth Rate (2013-2018)
5 North America Diabetes Drug by Countries
5.1 North America Diabetes Drug Sales, Revenue and Market Share by Countries
5.1.1 North America Diabetes Drug Sales and Market Share by Countries (2013-2018)
5.1.2 North America Diabetes Drug Revenue and Market Share by Countries (2013-2018)
5.2 United States Diabetes Drug Sales and Growth Rate (2013-2018)
5.3 Canada Diabetes Drug Sales and Growth Rate (2013-2018)
5.4 Mexico Diabetes Drug Sales and Growth Rate (2013-2018)
6 Europe Diabetes Drug by Countries
6.1 Europe Diabetes Drug Sales, Revenue and Market Share by Countries
6.1.1 Europe Diabetes Drug Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Diabetes Drug Revenue and Market Share by Countries (2013-2018)
6.2 Germany Diabetes Drug Sales and Growth Rate (2013-2018)
6.3 UK Diabetes Drug Sales and Growth Rate (2013-2018)
6.4 France Diabetes Drug Sales and Growth Rate (2013-2018)
6.5 Russia Diabetes Drug Sales and Growth Rate (2013-2018)
6.6 Italy Diabetes Drug Sales and Growth Rate (2013-2018)
7 Asia-Pacific Diabetes Drug by Countries
7.1 Asia-Pacific Diabetes Drug Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Diabetes Drug Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Diabetes Drug Revenue and Market Share by Countries (2013-2018)
7.2 China Diabetes Drug Sales and Growth Rate (2013-2018)
7.3 Japan Diabetes Drug Sales and Growth Rate (2013-2018)
7.4 Korea Diabetes Drug Sales and Growth Rate (2013-2018)
7.5 India Diabetes Drug Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Diabetes Drug Sales and Growth Rate (2013-2018)
8 South America Diabetes Drug by Countries
8.1 South America Diabetes Drug Sales, Revenue and Market Share by Countries
8.1.1 South America Diabetes Drug Sales and Market Share by Countries (2013-2018)
8.1.2 South America Diabetes Drug Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Diabetes Drug Sales and Growth Rate (2013-2018)
8.3 Argentina Diabetes Drug Sales and Growth Rate (2013-2018)
8.4 Colombia Diabetes Drug Sales and Growth Rate (2013-2018)
9 Middle East and Africa Diabetes Drug by Countries
9.1 Middle East and Africa Diabetes Drug Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Diabetes Drug Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Diabetes Drug Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Diabetes Drug Sales and Growth Rate (2013-2018)
9.3 UAE Diabetes Drug Sales and Growth Rate (2013-2018)
9.4 Egypt Diabetes Drug Sales and Growth Rate (2013-2018)
9.5 Nigeria Diabetes Drug Sales and Growth Rate (2013-2018)
9.6 South Africa Diabetes Drug Sales and Growth Rate (2013-2018)
10 Global Diabetes Drug Market Segment by Type
10.1 Global Diabetes Drug Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Diabetes Drug Sales and Market Share by Type (2013-2018)
10.1.2 Global Diabetes Drug Revenue and Market Share by Type (2013-2018)
10.2 Insulin Sales Growth and Price
10.2.1 Global Insulin Sales Growth (2013-2018)
10.2.2 Global Insulin Price (2013-2018)
10.3 Sensitizers Sales Growth and Price
10.3.1 Global Sensitizers Sales Growth (2013-2018)
10.3.2 Global Sensitizers Price (2013-2018)
10.4 SGLT-2 Inhibitors Sales Growth and Price
10.4.1 Global SGLT-2 Inhibitors Sales Growth (2013-2018)
10.4.2 Global SGLT-2 Inhibitors Price (2013-2018)
10.5 Alpha-glucosidase Inhibitors Sales Growth and Price
10.5.1 Global Alpha-glucosidase Inhibitors Sales Growth (2013-2018)
10.5.2 Global Alpha-glucosidase Inhibitors Price (2013-2018)
10.6 Secretagogues Sales Growth and Price
10.6.1 Global Secretagogues Sales Growth (2013-2018)
10.6.2 Global Secretagogues Price (2013-2018)
10.7 Peptide Analogs Sales Growth and Price
10.7.1 Global Peptide Analogs Sales Growth (2013-2018)
10.7.2 Global Peptide Analogs Price (2013-2018)
10.8 Others Sales Growth and Price
10.8.1 Global Others Sales Growth (2013-2018)
10.8.2 Global Others Price (2013-2018)
11 Global Diabetes Drug Market Segment by Application
11.1 Global Diabetes Drug Sales Market Share by Application (2013-2018)
11.2 Hospital Sales Growth (2013-2018)
11.3 Clinic Sales Growth (2013-2018)
11.4 Others Sales Growth (2013-2018)
12 Diabetes Drug Market Forecast (2018-2023)
12.1 Global Diabetes Drug Sales, Revenue and Growth Rate (2018-2023)
12.2 Diabetes Drug Market Forecast by Regions (2018-2023)
12.2.1 North America Diabetes Drug Market Forecast (2018-2023)
12.2.2 Europe Diabetes Drug Market Forecast (2018-2023)
12.2.3 Asia-Pacific Diabetes Drug Market Forecast (2018-2023)
12.2.4 South America Diabetes Drug Market Forecast (2018-2023)
12.2.5 Middle East and Africa Diabetes Drug Market Forecast (2018-2023)
12.3 Diabetes Drug Market Forecast by Type (2018-2023)
12.3.1 Global Diabetes Drug Sales Forecast by Type (2018-2023)
12.3.2 Global Diabetes Drug Market Share Forecast by Type (2018-2023)
12.4 Diabetes Drug Market Forecast by Application (2018-2023)
12.4.1 Global Diabetes Drug Sales Forecast by Application (2018-2023)
12.4.2 Global Diabetes Drug Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Diabetes Drug Picture
Table Product Specifications of Diabetes Drug
Figure Global Sales Market Share of Diabetes Drug by Types in 2017
Table Diabetes Dr
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
